Skip to content

Current behavioral neuroscience reports

ISSN 2196-2979

4 papers in the library · 117 citations · publishing 2015-2018

Papers

Sort Most recent Most cited

Current Understanding of the Neural Mechanisms of Dissociation in Borderline Personality Disorder

Current behavioral neuroscience reports February 12, 2018 Annegret Krause-Utz, Bernet M. Elzinga 34 citations

PURPOSE OF REVIEW: In this article, we aim to give an overview over recent neuroimaging research on dissociation in borderline personality disorder (BPD). Stress-related dissociation is highly prevalent in BPD, while so far only little is known about its neural underpinnings. RECENT FINDINGS: Based on research in depersonalization and the dissociative subtype of posttraumatic stress disorder,...

The Neural Mechanisms of Meditative Practices: Novel Approaches for Healthy Aging

Current behavioral neuroscience reports October 18, 2016 Bianca P. Acevedo, Sarah Pospos, Helen Lavretsky 83 citations

Meditation has been shown to have physical, cognitive, and psychological health benefits that can be used to promote healthy aging. However, the common and specific mechanisms of response remain elusive due to the diverse nature of mind–body practices. In this review, we aim to compare the neural circuits implicated in focused-attention meditative practices that focus on present-moment...

Current Trends in Identifying Rapidly Acting Treatments for Depression.

Current behavioral neuroscience reports June 1, 2016 Dawn F. Ionescu, George I. Papakostas

Traditional antidepressant medications generally take weeks-to-months to achieve effect. However, the breakthrough finding of ketamine's rapidly acting antidepressant properties has inspired a decade-and-a-half of progress towards the identification of treatments that work quickly-within hours-to-days. This paradigm-shift in the discovery of antidepressant therapies has significantly changed...

Novel Glutamatergic Treatments for Severe Mood Disorders.

Current behavioral neuroscience reports October 9, 2015 Minkyung Park, Mark J. Niciu, Carlos A. Zarate

All currently approved antidepressant medications for major depressive disorder (MDD) and bipolar disorder act primarily on the monoaminergic system and have varying affinities for serotonergic, norepinephrine-ergic, and/or dopaminergic receptors. Unfortunately, these drugs are only effective in approximately two-thirds of patients. Glutamate is the major excitatory neurotransmitter in the...

DOI: 10.1007/s40473-015-0050-5 (opens in new tab) Full text (opens in new tab) Glutamate Antagonist Mood disorders N-methyl-d-aspartate nmda +1